Physician

Rizwan Danish, MD

According to 2025 Medicare claims, Rizwan Danish, MD (NPI: 1720076284) practices hematology/oncology in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 48503-2044. Danish is affiliated with the McLaren High Performance Network, LLC (ACO ID: A3317), participating under the MSSP model.

Danish's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 488 traditional Medicare patients, billed 221,113 HCPCS/CPT codes, and received $4,032,945 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,155 prescription claims across 591 beneficiaries totaling $13,764,134 in drug costs, led by Erleada (Apalutamide). 2022 DME data shows 49 claims. Open Payments data shows 310 records totaling $7,730. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,135,778 to $13,764,134. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,661 to $255.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.2M2015 Medicare payment: $3,624,791 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $5,211,021 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,900,071 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,892,080 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,560,468 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,924,034 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $4,211,838 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,092,699 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $4,281,939 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,032,945 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015867391,479$3,624,791
2016869372,970$5,211,021
2017846287,612$4,900,071
2018730256,871$3,892,080
2019749220,270$3,560,468
2020721288,619$3,924,034
2021743283,183$4,211,838
2022627310,110$3,092,699
2023581296,771$4,281,939
2024488221,113$4,032,945

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.9M$14M2015 Drug cost: $3,135,778 (USD; Tot_Drug_Cst)2016 Drug cost: $3,138,038 (USD; Tot_Drug_Cst)2017 Drug cost: $4,060,027 (USD; Tot_Drug_Cst)2018 Drug cost: $5,229,084 (USD; Tot_Drug_Cst)2019 Drug cost: $6,906,524 (USD; Tot_Drug_Cst)2020 Drug cost: $7,959,002 (USD; Tot_Drug_Cst)2021 Drug cost: $11,499,976 (USD; Tot_Drug_Cst)2022 Drug cost: $12,307,140 (USD; Tot_Drug_Cst)2023 Drug cost: $12,448,854 (USD; Tot_Drug_Cst)2024 Drug cost: $13,764,134 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154783,619$3,135,778
20164953,526$3,138,038
20174963,645$4,060,027
20185383,810$5,229,084
20195073,424$6,906,524
20205273,189$7,959,002
20215743,867$11,499,976
20226203,896$12,307,140
20236434,432$12,448,854
20245914,155$13,764,134

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$17K$34K2015 Medicare payment: $33,961 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $20,959 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,333 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $14,460 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,828 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $1,267 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $31,689 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,480 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R181$33,961
2016N/R66$20,959
2017N/R58$2,333
20181197$14,460
2019N/R71$4,828
2020N/R29$1,267
2021N/R112$31,689
2022N/R49$1,480
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more236748$116
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more281380$77
80053Blood test, comprehensive group of blood chemicals2161,031$10
36415Insertion of needle into vein for collection of blood sample2881,696$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2741,712$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErleadaApalutamide1805,520$2,752,208
PomalystPomalidomide511,428$1,244,870
CalquenceAcalabrutinib Maleate722,160$1,110,304
JakafiRuxolitinib Phosphate571,710$958,890
XtandiEnzalutamide611,830$854,167

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.310$7,730Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rizwan Danish, MD?

Tedicare shows public-source Medicare data for Rizwan Danish, MD (NPI 1720076284), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rizwan Danish, MD have ACO affiliation data?

Rizwan Danish, MD is shown with ACO affiliation data for McLaren High Performance Network, LLC (MSSP, ACO ID A3317).

What billing organization is linked to Rizwan Danish, MD?

Rizwan Danish, MD is linked to CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (billing NPI 1528018389) in the available physician profile data.

Does Rizwan Danish, MD have Open Payments data?

Rizwan Danish, MD has 310 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.